Literature DB >> 27883881

Sofosbuvir and Daclatasvir Anti-Viral Therapy Fails to Clear HEV Viremia and Restore Reactive T Cells in a HEV/HCV Co-Infected Liver Transplant Recipient.

Mhairi C Donnelly1, Stuart N Imlach2, Florence Abravanel3, Sandeep Ramalingam4, Ingolfur Johannessen4, Juraj Petrik2, Alistair R Fraser5, John D M Campbell5, Peter Bramley6, Harry R Dalton7, Peter C Hayes1, Nassim Kamar8, Kenneth J Simpson9.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27883881     DOI： 10.1053/j.gastro.2016.05.060

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  20 in total

1.  Antiviral Candidates for Treating Hepatitis E Virus Infection.

Authors:  Natalie E Netzler; Daniel Enosi Tuipulotu; Subhash G Vasudevan; Jason M Mackenzie; Peter A White
Journal:  Antimicrob Agents Chemother       Date:  2019-05-24       Impact factor: 5.191

2.  Potent Inhibition of Hepatitis E Virus Release by a Cyclic Peptide Inhibitor of the Interaction between Viral Open Reading Frame 3 Protein and Host Tumor Susceptibility Gene 101.

Authors:  Saumya Anang; Nidhi Kaushik; Smita Hingane; Anita Kumari; Jyoti Gupta; Shailendra Asthana; Baibaswata Nayak; C T Ranjith-Kumar; Milan Surjit
Journal:  J Virol       Date:  2018-09-26       Impact factor: 5.103

3.  Autochthonous acute hepatitis E: treatment with sofosbuvir and ribavirin.

Authors:  Elisa Biliotti; Cristiana Franchi; Martina Spaziante; Anna Rosa Garbuglia; Lorenzo Volpicelli; Donatella Palazzo; Maurizio De Angelis; Rozenn Esvan; Gloria Taliani
Journal:  Infection       Date:  2018-06-26       Impact factor: 3.553

Review 4.  Sofosbuvir in the Treatment of Hepatitis E virus Infection: A Review of in vitro and in vivo Evidence.

Authors:  Temi Lampejo
Journal:  J Clin Exp Hepatol       Date:  2022-02-22

5.  Interferon-alpha treatment rapidly clears Hepatitis E virus infection in humanized mice.

Authors:  Martijn D B van de Garde; Suzan D Pas; Gertine W van Oord; Lucio Gama; Youkyung Choi; Robert A de Man; Andre Boonstra; Thomas Vanwolleghem
Journal:  Sci Rep       Date:  2017-08-15       Impact factor: 4.379

6.  Nucleoside analogue 2'-C-methylcytidine inhibits hepatitis E virus replication but antagonizes ribavirin.

Authors:  Changbo Qu; Lei Xu; Yuebang Yin; Maikel P Peppelenbosch; Qiuwei Pan; Wenshi Wang
Journal:  Arch Virol       Date:  2017-06-16       Impact factor: 2.574

7.  BALB/c Mouse Is a Potential Animal Model System for Studying Acute and Chronic Genotype 4 Hepatitis E Virus Infection.

Authors:  Yunlong Li; Feiyan Long; Chenchen Yang; Xianhui Hao; Jian Wu; Jianwen Situ; Shuangfeng Chen; Zhongyao Qian; Fen Huang; Wenhai Yu
Journal:  Front Microbiol       Date:  2020-06-16       Impact factor: 5.640

8.  Sofosbuvir Add-on to Ribavirin Treatment for Chronic Hepatitis E Virus Infection in Solid Organ Transplant Recipients Does Not Result in Sustained Virological Response.

Authors:  E M van Wezel; J de Bruijne; K Damman; M Bijmolen; A P van den Berg; E A M Verschuuren; G A Ruigrok; A Riezebos-Brilman; M Knoester
Journal:  Open Forum Infect Dis       Date:  2019-08-01       Impact factor: 3.835

9.  Increased Mast Cell Activation in Mongolian Gerbils Infected by Hepatitis E Virus.

Authors:  Tianlong Liu; Peng Xiao; Ruiwen Li; Ruiping She; Jijing Tian; Jingyuan Wang; Jingjing Mao; Jun Yin; Ruihan Shi
Journal:  Front Microbiol       Date:  2018-10-02       Impact factor: 5.640

Review 10.  Recent Advances Towards the Development of a Potent Antiviral Against the Hepatitis E Virus.

Authors:  Saumya Anang; Nidhi Kaushik; Milan Surjit
Journal:  J Clin Transl Hepatol       Date:  2018-06-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.